Tag: Neuraminidase inhibitors

Globally, influenza affects millions each year, but fortunately, multiple antiviral medications are available to combat the virus by interfering with its life cycle. Understanding what is the mechanism of action of anti influenza drugs reveals how these therapies can stop the infection from spreading and lessen its severity.

When administered early in the course of illness, neuraminidase inhibitors can significantly reduce the duration and severity of influenza symptoms. This class of antiviral medications specifically targets and inhibits the neuraminidase protein found on the surface of influenza viruses, effectively stopping the infection from spreading within the body.

The average retail price for a single course of Rapivab can exceed $900, not including administration fees [1.2.1, 1.3.1]. For those with acute uncomplicated influenza, understanding treatment options is critical. This raises the question: **How much does Rapivab cost** as a single-dose intravenous (IV) treatment?